Dr. Yaning Wang US Food and Drug Administration

1 Talk

Dr. Yaning Wang is currently the Deputy Director in the Division of Pharmacometrics in the Office of Clinical Pharmacology at FDA. Before joining FDA, Dr. Wang received his Ph.D. in Pharmaceutics and master’s degree in Statistics from the University of Florida from 1999 to 2003. He also obtained a master’s... read moredegree in Biochemistry (1999) from National Doping Control Center and a bachelor’s degree in Pharmacy (1996) from Peking University in China. At his current position, Dr. Wang oversees the scientific aspects of reviews, research projects, and policy development within the Division of Pharmacometrics for all disease areas. During his over eleven years of service at FDA, Dr. Wang received numerous awards, including Award of Merit (the most prestigious honor awarded at FDA) and FDA Outstanding Service Award. Dr. Wang is an Adjunct Professor in the Department of Pharmaceutics at the University of Florida, an Adjunct Professor in the School of Pharmacy at Health Science Center in Peking University, a guest professor in Peking University Clinical Research Institute and an invited lecturer in the College of Engineering and College of Pharmacy at the University of Michigan. Dr. Wang is the chair of the FDA working group to draft a new guidance for the industry to optimize dose selection during the clinical development stage. Dr. Wang has been on the FDA Regulatory Science and Review Enhancement (RSR) Review Committee for five years. Dr. Wang has been the lead on multiple consults from other FDA offices/centers such as Office of Generic Drug (OGD) and Center for Devices and Radiological Health (CDRH). Dr. Wang serves as the expert reviewer for grant applications to National Institutes of Health (NIH), U.S. Department of Health and Human Services. Dr. Wang served as a committee member for multiple Ph.D. candidates from various universities. He mentored twenty-two former research fellows (visiting scholars, post-doctoral scholars, and Ph.D. candidates) at FDA and is mentoring five current research fellows at FDA. Dr. Wang is an invited manuscript reviewer for fifteen scientific journals in the medical, pharmaceutical and statistical areas. He has published 40 papers and given 90 presentations at various national and international meetings. He is a member of the Advisory Committee for Chinese Pharmacometrics Society and a member of the Editorial Advisory Board for the Journal of Pharmacokinetics and Pharmacodynamics. He is also on Board of Directors for International Society of Pharmacometrics (ISoP).